Gara Jalqabaatti › Kansarii Ovarii › California › San Diego
Qorannoo klinikaalii Kansarii Ovarii San Diego, CA keessatti
Qorannoo 24 Kansarii Ovarii f San Diego fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Namoota walitti qabaa jiraSadarkaa 2
- UC San Diego Medical Center - Hillcrest, San Diego
- Sharp Memorial Hospital, San Diego
- UC San Diego Moores Cancer Center, La Jolla · Miili 11 fagaatti
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- University of California, San Diego (UCSD) - Moores Cancer Center, La Jolla · Miili 11 fagaatti
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Namoota walitti qabaa jiraSadarkaa 1/2
- University of San Diego Moores Cancer Center, La Jolla · Miili 11 fagaatti
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
Namoota walitti qabaa jiraSadarkaa 2
- Scripps Md Anderson - Prebys Cancer Center /ID# 276891, San Diego
DESTINY-PANTUMOUR04
Namoota walitti qabaa jiraQorannoo ilaalaa
- Research Site, San Diego
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
Namoota walitti qabaa jiraQorannoo ilaalaa
- University of California San Diego, La Jolla · Miili 11 fagaatti
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
Namoota walitti qabaa jiraSadarkaa 3
- Moores Cancer Center, La Jolla · Miili 11 fagaatti
A Study to Assess Adverse Events and Change in Disease Activity of Multiple Treatment Combinations With Intravenous Mirvetuximab Soravtansine in Adult Participants With Ovarian Cancer
Namoota walitti qabaa jiraSadarkaa 2
- UC San Diego Health - Moores Cancer Center /ID# 277574, La Jolla · Miili 11 fagaatti
Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
Namoota walitti qabaa jiraSadarkaa 3
- University of California, San Diego-Moores Cancer Center, La Jolla · Miili 11 fagaatti
A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
Namoota walitti qabaa jiraSadarkaa 2
- Scripps Healthscripps Mercy Hospital Prebys Cancer Center, San Diego
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Namoota walitti qabaa jiraQorannoo ilaalaa
- University of California, San Diego, La Jolla · Miili 11 fagaatti
Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer
Namoota walitti qabaa jiraSadarkaa 2
- UC San Diego Health, La Jolla · Miili 11 fagaatti
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- Scripps Health, San Diego
A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- University of California, San Diego (UCSD) - Moores Cancer Center, La Jolla · Miili 11 fagaatti
FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- UC San Diego Moores Cancer Center, La Jolla · Miili 11 fagaatti
Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)
Namoota walitti qabaa jiraSadarkaa 3
- UC San Diego Health - Moores Cancer Center, La Jolla · Miili 11 fagaatti
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Namoota walitti qabaa jiraSadarkaa 3
- Kaiser Permanente-San Diego Zion, San Diego
- UC San Diego Moores Cancer Center, La Jolla · Miili 11 fagaatti
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
Namoota walitti qabaa jiraSadarkaa 1/2
- University of California, San Diego; Moores Cancer Center, San Diego
Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- Investigative Site #101, La Jolla · Miili 11 fagaatti
Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)
Namoota walitti qabaa jiraSadarkaa 3
- Scripps Clinic, La Jolla · Miili 11 fagaatti
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
Namoota walitti qabaa jiraSadarkaa 1/2
- UCSD Moores Cancer Center, La Jolla · Miili 11 fagaatti
Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer
Namoota walitti qabaa jiraSadarkaa 3
- University of California San Diego Moores Cancer Center, La Jolla · Miili 11 fagaatti
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Namoota walitti qabaa jiraQorannoo ilaalaa
- Massive Bio SYNERGY-AI site, La Jolla · Miili 11 fagaatti
A Beta-only IL-2 ImmunoTherapY Study
Namoota walitti qabaa jiraSadarkaa 1/2
- Sharp Memorial Hospital, San Diego
Qorannoo Kansarii Ovarii magaalota biroo keessatti
- Houston, TXQorannoo 89
- New York City, NYQorannoo 69
- Boston, MAQorannoo 61
- Los Angeles, CAQorannoo 50
- Nashville, TNQorannoo 49
- Arlington, VAQorannoo 46
- Philadelphia, PAQorannoo 44
- Columbus, OHQorannoo 39
- St. Louis, MOQorannoo 38
- Chicago, ILQorannoo 36
- San Antonio, TXQorannoo 31
- Cleveland, OHQorannoo 30
Qorannoo biroo San Diego keessatti
- Kansara Qara'a Non-Small CellQorannoo 48
- Saree OljooQorannoo 41
- Saree (Gosoota Hunda)Qorannoo 32
- Kansarii ProstateQorannoo 31
- Kansara MetastatikiiQorannoo 30
- Kansarii ColorectalQorannoo 25
- Kansarii PancreasQorannoo 24
- Dhibee QaraQorannoo 23
- ObesityQorannoo 23
- Cufama OnneeQorannoo 23
- DepreshiniiQorannoo 21
- MelanomaQorannoo 18
Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.